Cowan RA - Search Results

1

Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia.

Ralston SH, Gallacher SJ, Patel U, Dryburgh FJ, Fraser WD, Cowan RA, Boyle IT. Ralston SH, et al. Among authors: cowan ra. Lancet. 1989 Nov 18;2(8673):1180-2. doi: 10.1016/s0140-6736(89)91791-1. Lancet. 1989. PMID: 2572902 Clinical Trial.

2

Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancy.

Gallacher SJ, Fraser WD, Logue FC, Dryburgh FJ, Cowan RA, Boyle IT, Ralston SH. Gallacher SJ, et al. Among authors: cowan ra. Calcif Tissue Int. 1992 Dec;51(6):419-23. doi: 10.1007/BF00296674. Calcif Tissue Int. 1992. PMID: 1333351

3

Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study.

Gallacher SJ, Fenner JA, Anderson K, Bryden FM, Banham SW, Logue FC, Cowan RA, Boyle IT. Gallacher SJ, et al. Among authors: cowan ra. Thorax. 1992 Nov;47(11):932-6. doi: 10.1136/thx.47.11.932. Thorax. 1992. PMID: 1465751 Free PMC article.

4

A comparison of low versus high dose pamidronate in cancer-associated hypercalcaemia.

Gallacher SJ, Ralston SH, Fraser WD, Dryburgh FJ, Cowan RA, Logue FC, Boyle IT. Gallacher SJ, et al. Among authors: cowan ra. Bone Miner. 1991 Dec;15(3):249-56. doi: 10.1016/0169-6009(91)90130-r. Bone Miner. 1991. PMID: 1773137

5

Hypercalcaemia of malignancy.

Ralston SH, Dryburgh FJ, Cowan RA, Boyce BF, Gardner MD, Boyle IT. Ralston SH, et al. Among authors: cowan ra. Lancet. 1985 Apr 13;1(8433):878. doi: 10.1016/s0140-6736(85)92241-x. Lancet. 1985. PMID: 2858738 No abstract available.

6

Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

Ralston SH, Gardner MD, Dryburgh FJ, Jenkins AS, Cowan RA, Boyle IT. Ralston SH, et al. Among authors: cowan ra. Lancet. 1985 Oct 26;2(8461):907-10. doi: 10.1016/s0140-6736(85)90848-7. Lancet. 1985. PMID: 2865417 Clinical Trial.

7

Treatment of severe hypercalcaemia with mithramycin and aminohydroxypropylidene bisphosphonate.

Ralston SH, Gallacher SJ, Dryburgh FJ, Cowan RA, Boyle IT. Ralston SH, et al. Among authors: cowan ra. Lancet. 1988 Jul 30;2(8605):277. doi: 10.1016/s0140-6736(88)92563-9. Lancet. 1988. PMID: 2899259 No abstract available.

8

Clinical experience with aminohydroxypropylidene bisphosphonate (APD) in the management of cancer-associated hypercalcaemia.

Ralston SH, Alzaid AA, Gallacher SJ, Gardner MD, Cowan RA, Boyle IT. Ralston SH, et al. Among authors: cowan ra. Q J Med. 1988 Oct;68(258):825-34. Q J Med. 1988. PMID: 3268894

9

Comparison of intestinal calcium absorption and circulating 1,25-dihydroxyvitamin D levels in malignancy-associated hypercalcaemia and primary hyperparathyroidism.

Ralston SH, Cowan RA, Gardner MD, Fraser WD, Marshall E, Boyle IT. Ralston SH, et al. Among authors: cowan ra. Clin Endocrinol (Oxf). 1987 Mar;26(3):281-91. doi: 10.1111/j.1365-2265.1987.tb00785.x. Clin Endocrinol (Oxf). 1987. PMID: 3652475

10

Hypercalcaemia in rheumatoid arthritis revisited.

Ralston SH, Fraser WD, Jankowski J, Richards IM, Cowan RA, Capell HA, Sturrock RD. Ralston SH, et al. Among authors: cowan ra. Ann Rheum Dis. 1990 Jan;49(1):22-4. doi: 10.1136/ard.49.1.22. Ann Rheum Dis. 1990. PMID: 2310223 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page